Tag: Innoplexus AG- COVID-19 Response

Frankfurt-headquartered Innoplexus announces major findings in potential combination therapies for Covid-19

Innoplexus AG announced some first results in its artificial intelligence enabled search for a COVID-19 antiviral treatment. Innoplexus began by scanning data on previously approved drugs for off-label potential in treating COVID-19, using its proprietary artificial intelligence (AI) and big data platform to generate actionable insights from hundreds of terabytes of structured and unstructured public…

COVID-19 Response: Innoplexus opens its AI search platform Ontosight to medical researchers

Innoplexus AG has made its proprietary Ontosight AI search platform available to medical researchers around the globe to help fight the COVID-19 pandemic with immediate effect. The platform is already being used by researchers from Germany, USA, and India. ‘Flattening the curve’ necessitates health organizations to take on early measures focused on containment. Various countries,…